Live price temporarily unavailable.
Hyperliquid Strategies (PURR) is a Health Care company in the Russell 2000. Latest news and coverage below.
| FY2026Jun 2026 | |
|---|---|
| Income statement | |
| Revenue | $9.46M |
| Operating income | $500.6M |
| Operating margin | 5292.0% |
| Net income | $305.5M |
| Net margin | 3229.8% |
| EPS (diluted) | $3.21 |
| Balance sheet | |
| Cash and equivalents | $137.9M |
| Total assets | $2.06B |
| Total liabilities | $187.1M |
| Shareholders' equity | $1.87B |
| Cash flow | |
| Operating cash flow | −$19.1M |
| Share buybacks | $10.5M |
| Q1 FY26†Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 | |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0 | $500.0K | $2.63M | — |
| Operating income | −$13.4M | −$287.5M | $193.8M | — |
| Operating margin | — | −57509.2% | 7380.6% | — |
| Net income | −$13.4M | −$304.5M | $152.5M | — |
| Net margin | — | −60892.6% | 5807.7% | — |
| EPS (diluted) | −$13183.92 | −$7.43 | $1.01 | — |
| Balance sheet | ||||
| Cash and equivalents | — | $281.9M | $113.1M | $137.9M |
| Total assets | — | $616.6M | $810.4M | $2.06B |
| Total liabilities | $1.21M | $26.9M | $66.9M | $187.1M |
| Shareholders' equity | −$13.7M | $589.8M | $743.5M | $1.87B |
| Cash flow | ||||
| Operating cash flow | $0 | −$8.31M | −$7.00M | — |
| Share buybacks | — | — | $1.14M | — |
From Hyperliquid Strategies's 10-K and 10-Q filings with the SEC; its fiscal year ends in June. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Hyperliquid Strategies in our feed yet.